DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for salpingitis — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSalpingitis maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for salpingitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Gynecologic Surgery · 1993 · 4 citations
Proposed Criteria for the Selection of Patients for Ambulatory Therapy of Acute Gonococcal Salpingitis
AbstractNo firm criteria have existed that delineate which patients with acute gonococcal salpingitis can be managed successfully on an outpatient basis and which patients would be best handled by hospitalization. This article describes one individual's rationale for selecting candidates for ambulatory therapy of acute salpingitis.
Journal of obstetrics and women s diseases · 2020 · 0 citations · open access
False dermoid ovarian cysts that developed after oophoropexy
AbstractIn a 30-year-old woman who had previously had her left appendages removed due to their inflammatory disease, the authors used a conservative method to treat right-sided salpingitis, temporarily securing the tube and ovary in the abdominal wound with sutures, followed by catheterization of the tube.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
